Ozcan Refik, Jarolim Petr, Lux Samuel E, Ungewickell Ernst, Eber Stefan W
Universitäts-Kinderklinik, Goettingen, Germany.
Br J Haematol. 2003 Aug;122(4):669-77. doi: 10.1046/j.1365-2141.2003.04479.x.
Nonsense/stop mutations in the ankyrin-1 gene (ANK1) are a major cause of dominant HS (dHS) (frequency of 23% in German dHS patients). To date, no common mutation has been found and therefore a simple mutation screening is not feasible. The reduced expression of one cDNA allele in the (AC)n microsatellite polymorphism of the ankyrin-1 gene, as seen in about 20% of Czech patients with dHS, may identify candidates with a possible frameshift/nonsense mutation. In order to verify the efficiency of this screening we screened the ankyrin-1 gene of 22 Czech dHS patients for both the reduced cDNA allele expression in the frequent (AC)n and the common exonic 26/39 polymorphisms, as well as for polymerase chain reaction (PCR) single-stranded conformation polymorphisms in any one of the 42 exons of ANK1. Anomalous PCR products were sequenced. We found seven new ANK1 frameshift/nonsense mutations in nine patients with, but in none of six patients without, a reduced cDNA allele expression (efficiency of 78%). We conclude that screening of dHS patients for such a reduced allele expression in common ANK1 polymorphisms is an efficient procedure for the identification of candidates for frameshift/nonsense mutations in the ankyrin-1 gene.
锚蛋白-1基因(ANK1)中的无义/终止突变是显性遗传性球形红细胞增多症(dHS)的主要病因(在德国dHS患者中的发生率为23%)。迄今为止,尚未发现常见突变,因此简单的突变筛查不可行。在约20%的捷克dHS患者中观察到,锚蛋白-1基因(AC)n微卫星多态性中一个cDNA等位基因的表达降低,这可能识别出存在可能的移码/无义突变的候选者。为了验证这种筛查的效率,我们对22例捷克dHS患者的锚蛋白-1基因进行了筛查,检测常见(AC)n中cDNA等位基因表达降低情况、常见的外显子26/39多态性,以及ANK1的42个外显子中任何一个的聚合酶链反应(PCR)单链构象多态性。对异常PCR产物进行测序。我们在9例cDNA等位基因表达降低的患者中发现了7个新的ANK1移码/无义突变,但在6例cDNA等位基因表达未降低的患者中均未发现(效率为78%)。我们得出结论,对dHS患者进行常见ANK1多态性中这种等位基因表达降低情况的筛查,是识别锚蛋白-1基因移码/无义突变候选者的有效方法。